Application of biosafety principles in blood establishments.
In light of increasing public and employee concern over potential infectious hazards associated with blood and other body fluids, several government agencies (the Food and Drug Administration, the Centers for Disease Control, the Occupational Safety and Health Administration, the Environmental Protection Agency, the Health Care Financing Administration and the National Heart, Lung and Blood Institute) cosponsored a Biosafety Workshop in April 1988. The objective of the workshop was to identify appropriate biosafety practices and standard control procedures to protect workers involved in the collection, storage, and transportation of human blood donations with the least possible disruption of the nation's blood supply. Speakers focused on human immunodeficiency virus (HIV) and hepatitis B virus (HBV); however, the safety principles discussed were considered equally applicable to other known (e.g., non-A, non-B hepatitis and human T-lymphotropic virus type I (HTLV-1) blood-transmitted infections. The resulting consensus included the need for blood establishments to develop and apply thoughtful biosafety programs to address staff training, accident prevention, HBV vaccination, handling spills, managing contaminated waste and transporting blood specimens. There was lack of agreement, however, on the usefulness of gloves during the phlebotomy of healthy blood donors.
Department of Pathology, Stanford University Medical Center, Palo Alto, CA 94304.
F C
FC
Grumet
J L
JL
MacPherson
P A
PA
Hoppe
L A
LA
Smallwood
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality / Q000635:transmission; D001771:Blood Banks; D003264:Containment of Biohazards / Q000706:statistics & numerical data*; D006801:Humans